tradingkey.logo
搜索

Can Fite Biopharma Ltd

CANF
添加自选
3.170USD
-0.110-3.35%
收盘 07-31 16:00美东报价延迟15分钟
27.67K总市值
亏损市盈率 TTM

关于 Can Fite Biopharma Ltd 公司

Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Can Fite Biopharma Ltd简介

公司代码CANF
公司名称Can Fite Biopharma Ltd
上市日期Sep 22, 2005
CEOFishman (Pnina)
员工数量5
证券类型Depository Receipt
年结日Sep 22
公司地址10 Bareket Street, Kiryat Matalon
城市PETAH TIKVA
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家Israel
邮编49170
电话97239241114
网址https://www.canfite.com/
公司代码CANF
上市日期Sep 22, 2005
CEOFishman (Pnina)

Can Fite Biopharma Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--

常见问题

Can Fite Biopharma Ltd的前五大股东是谁?

Can Fite Biopharma Ltd 的前五大股东如下:Dr. Pnina Fishman, Ph.D.

有多少机构持有Can Fite Biopharma Ltd(CANF)的股份?

截至2026Q1,共有28家机构持有Can Fite Biopharma Ltd的股份,合计持有的股份价值约为32.13K,占公司总股份的1.50%。与2025Q4相比,机构持股有所增加,增幅为-81636.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有